Standout Papers
Immediate Impact
63 standout
Citing Papers
Tailoring traditional Chinese medicine in cancer therapy
2025 Standout
The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Works of Feng Luo being referenced
The Research Progress of Antiangiogenic Therapy, Immune Therapy and Tumor Microenvironment
2022
Low pretreatment lymphocyte/monocyte ratio is associated with the better efficacy of neoadjuvant chemotherapy in breast cancer patients
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Feng Luo | 455 | 266 | 163 | 57 | 894 | |
| Frederik J.H. Hoogwater | 352 | 291 | 122 | 52 | 792 | |
| Iris Tischoff | 393 | 419 | 157 | 49 | 1.0k | |
| Ming Jiang | 399 | 231 | 128 | 65 | 1.0k | |
| Limei Qu | 326 | 207 | 270 | 63 | 875 | |
| Kazuki Takakura | 397 | 323 | 93 | 66 | 988 | |
| Quan P. Ly | 387 | 316 | 131 | 42 | 873 | |
| Haijun Zhong | 347 | 310 | 273 | 57 | 1.1k | |
| Anuhya Kommalapati | 577 | 289 | 242 | 61 | 1.1k | |
| Elsie Oppermann | 206 | 293 | 130 | 57 | 964 | |
| Takahiro Einama | 481 | 181 | 288 | 81 | 842 |
All Works
Login with ORCID to disown or claim papers
Loading papers...